CLINICAL STUDY ON 9, 3''-DI-O-ACETYL-MIDECAMYCIN (MOM)

Abstract

Clinical investigation on 9, 3''-di-o-acetyl midecamycin (MOM) showed the following results.
1. MOM showed an inhibitory action against gram positive cocci.
2. MOM was applied singly 600 mg per day for the mild respiratory tract infection, and excellent or good results were obtained in 16 cases out of 20 cases.
3. Side effect was observed in 2 cases, that showed slight GOT and GPT elevation one week after the start of MOM administration.